Literature DB >> 1830240

Angioplasty after laser perforation.

J A Reekers1, R L Sprangers, A J van de Kley.   

Abstract

Perforation is the most important complication of laser angioplasty and leads to a decrease in success because the procedure has to be discontinued. In 3 patients we continued despite perforation and were able to stop extravasation with percutaneous transluminal angioplasty (PTA) and to finish the procedure with a good final result. From our experience we conclude that laser perforation is not an absolute indication to stop the procedure if PTA in the recanalized lumen is possible.

Entities:  

Mesh:

Year:  1991        PMID: 1830240     DOI: 10.1007/bf02577707

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  4 in total

Review 1.  Vascular applications of laser.

Authors:  A H Cragg; G A Gardiner; T P Smith
Journal:  Radiology       Date:  1989-09       Impact factor: 11.105

2.  Percutaneous laser thermal angioplasty: initial results and 1-year follow-up in 129 femoropopliteal lesions.

Authors:  T A Sanborn; D C Cumberland; A J Greenfield; C L Welsh; J K Guben
Journal:  Radiology       Date:  1988-07       Impact factor: 11.105

3.  Percutaneous transluminal laser angioplasty with contact probes.

Authors:  J Lammer; F Karnel
Journal:  Radiology       Date:  1988-09       Impact factor: 11.105

4.  Percutaneous transluminal laser angioplasty for treatment of peripheral vascular disease. Clinical experience with 16 patients.

Authors:  R Ginsburg; L Wexler; R S Mitchell; D Profitt
Journal:  Radiology       Date:  1985-09       Impact factor: 11.105

  4 in total
  1 in total

1.  The "Fracking" technique: a novel approach to crack deep calcified plaque in the common femoral artery with hydraulic pressure.

Authors:  Takuya Haraguchi; Tsutomu Fujita; Yoshifumi Kashima; Masanaga Tsujimoto; Tsuyoshi Takeuchi; Yutaka Tadano; Daisuke Hachinohe; Umihiko Kaneko; Ken Kobayashi; Daitaro Kanno; Katsuhiko Sato
Journal:  CVIR Endovasc       Date:  2021-09-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.